Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
15.21
-0.32 (-2.09%)
Sep 3, 2026, 11:24 AM EDT - Market open
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $951.55 million as of September 3, 2026. Its market cap has increased by 191.61% in one year.
Market Cap
951.55M
Enterprise Value
746.82M
1-Year Change
191.61%
Ranking
Category
Stock Price
$15.21
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $951.55M, a decrease of -56.87%. That is a compound annual growth rate of -14.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 951.55M | 78.09% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Faeth Therapeutics | 1.01B |
| Candel Therapeutics | 1.01B |
| Arbutus Biopharma | 1.01B |
| Immix Biopharma | 998.69M |
| Lexicon Pharmaceuticals | 996.70M |
| Attovia Therapeutics | 995.26M |
| Wave Life Sciences | 961.60M |
| Olema Pharmaceuticals | 947.60M |